by Vora Corporate Finance | Jan 21, 2023 | Capital Market Updates, Insights
Trends in Secondary Markets: The BSE Sensex was up by 2,353.06 points or 3.87% at 63,099.65 and NIFTY was up by 746.15 points or 4.20% at 18,758.35. FPI infused funds worth Rs 32,344 Crores in November. The rally was also driven by domestic players. Earnings growth in...
by Vora Corporate Finance | Jan 21, 2023 | Insights
Economic Update: The Reserve Bank of India (RBI) in its monetary policy meeting held on December 7, 2022 has yet again hiked the repo rate by 0.35%. This is the fifth consecutive repo rate hike since May of this year. The repo rate will go up from 5.9% to 6.25%. RBI...
by Vora Corporate Finance | Jan 2, 2023 | Insights, Merger & Acquisitions
Transaction: Private equity player Advent International has entered into a definitive agreement to acquire significant stake in Suven Pharmaceuticals from the Jasti family. Advent will also be making an open offer to acquire additional 26% (entailing a total outgo of...
by Vora Corporate Finance | Dec 31, 2022 | Insights, Private Equity & IPO
Transaction: HealthKart Bags $135 Mn in Series H Funding Round Led by Temasek, 91 Partners and Kae Capital for valuation around $350-400 million (around Rs. 3000 Crore). The startup, also counts Sequoia India, Sofina and IIFL among its backers, has raised about $200...
by Vora Corporate Finance | Sep 12, 2022 | Insights, Private Equity & IPO
Transaction: Accumax Lab Devices Pvt. Ltd (“Accumax”), a leading provider of lab equipment and consumables, has raised its first private equity funding of $68 million (around Rs. 520 crore) from Creador and InvAscent. About Accumax: Incorporated in 2003 by...
